PDLI R&D Expenses
Pdl Biopharma Inc · R&D Expenses

PDLI R&D Expenses
Latest reported$0.00period ending
PDLI Quarterly R&D Expenses ($8.50M → $0.00)
Quarterly R&D Expenses
High-resolution chart · PNG
PDLI r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 0 | |
| 1,465,000 | |
| 1,856,000 | |
| 1,243,000 | |
| 4,310,000 | |
| 886,000 | |
| 869,000 | |
| 806,000 | |
| 672,000 | |
| 684,000 | |
| 793,000 | |
| 729,000 | |
| 605,000 | |
| 4,281,000 | |
| 1,766,000 | |
| 1,887,000 | |
| 1,933,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 44,718,000 | |
| 40,400,000 | |
| 47,681,000 | |
| 27,082,000 | |
| 55,964,000 | |
| 67,086,000 | |
| 55,625,000 | |
| 65,397,000 | |
| 70,880,000 | |
| 62,612,000 | |
| 61,771,000 | |
| 46,959,000 | |
| 49,480,000 | |
| 40,339,000 | |
| 35,261,000 | |
| 30,199,000 | |
| 27,326,000 | |
| 32,009,000 | |
| 33,029,000 | |
| 22,777,000 | |
| 22,505,000 | |
| 21,058,000 | |
| 16,392,000 | |
| 15,710,000 | |
| 14,306,000 | |
| 14,774,000 | |
| 13,187,000 | |
| 13,831,000 | |
| 12,463,000 | |
| 12,207,000 | |
| 13,671,000 | |
| 11,608,000 | |
| 9,442,000 | |
| 10,216,000 | |
| 11,069,000 | |
| 11,400,000 | |
| 7,900,000 | |
| 8,500,000 | |
| 8,300,000 | |
| 8,900,000 | |
| 8,900,000 | |
| 7,300,000 | |
| 6,400,000 | |
| 6,500,000 | |
| 6,300,000 | |
| 6,300,000 | |
| 6,500,000 | |
| 6,700,000 | |
| 8,500,000 |